E. Bel (Amsterdam, The Netherlands), R. Dahl (Aarhus, Denmark)
T regulatory cells decrease before asthma exacerbations
K. Botturi-Cavailles, Y. Lacoeuille, A. Nieves, D. Pinot, D. Vervloet, A. Magnan (Marseille, France)
|  |
Exhaled breath condensate eicosanoids as markers of asthma severity
W. Piotrowski, A. Antczak, J. Marczak, Z. Kurmanowska, A. Rutko, P. Górski (Lodz, Poland)
|  |
Toll-like receptor 4 expression in the large airways of fatal asthma
D. S. Ferreira, L. F. F. Silva, A. B. G. Santos, M. C. R. Medeiros, M. Dolhnikoff, T. Mauad (Sao Paulo/SP, Brazil)
| |
Pulmonary inflammatory cells strongly express IL-18 in asthma death cases
Y. Sakazaki, T. Hoshino, S. Takei, M. Okamoto, T. Kinoshita, H. Imaoka, T. Iwanaga, S. Kato, H. Aizawa (Kurume, Okinawa, Japan)
| |
Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, circulating monocytes in patients with severe asthma
M. Moniuszko, K. Kowal, D. Lenczewska, M. Dabrowska, A. Bodzenta-Lukaszyk (Bialystok, Poland)
|  |
Comparison of skin prick tests with specific serum IgE (RAST test) in the diagnosis of fungal sensitisation in patients with severe asthma
B. R. O‘Driscoll, G. Powell, F. Chew, R. Niven, A. Vyas, J. Miles, D. Denning (Salford, Manchester, Preston, United Kingdom)
| |
The incidence of nasal polyps and corresponding LTE4 levels in severe asthma
C. Micheletto, F. Trevisan, S. Bertacco, M. Visconti, R. Dal Negro (Bussolengo – VR, Italy)
| |
The economic impact of severe asthma to low-income families
R. Franco, A. A. Cruz, H. F. Nascimento, A. C. Santos, L. C. Rodrigues, M. L. Barreto (Salvador – Bahia, Brazil)
| |